Oslo, Norway, 19. January 2016: Serodus ASA (Oslo Axess: SER), a company focusing on the development of novel treatment of cardiovascular and metabolic diseases, announces, that Anthony Rosenberg has joined the company as an advisor. SERODUS is in the process of building a strong group of advisors to assist management in business development, strategy, licensing and corporate development.

Anthony Rosenberg served as Global Head M & A / licensing until February 2015 and in that role was responsible for Corporate M & A / Licensing across all Novartis divisions. This included execution of the Novartis Portfolio Transformation, comprising asset swaps/ divestments across several business sectors, which is currently seen as a unique set of transactions in the industry. Prior to this role Mr. Rosenberg was Global Head Business Development and Licensing, Novartis Pharma for 7 years. Earlier in his career in Novartis he was Head of Transplant /Immunology Global Business Unit , after several marketing leadership roles.

Mr. Rosenberg has a B.Sc. (Hons) from University of Leicester, a M.Sc. Physiology from University of London.

'We are thrilled with the addition of Mr. Rosenberg to our team of advisors,' said Prof. Eva Steiness, CEO of SERODUS. 'His wealth of expertise, and the professional network that Mr. Rosenberg brings to SERODUS is going to be very valuable as we move our product candidates forward into later stage clinical development.

For further questions please contact:

Tore Kvam

CFO, Serodus ASA

Mobile: +47 959 34 199

e-mail: tore.kvam@serodus.com

Serodus ASA is a Norwegian drug development company, focusing on new therapeutic products for the treatment of cardiovascular and metabolic diseases with large unmet clinical needs. The company's business model is to seek partnering with international pharmaceutical companies after having demonstrated clinical effect in humans. For more information see www.serodus.com.

Serodus ASA issued this content on 2016-01-19 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-19 08:02:04 UTC

Original Document: http://www.serodus.com/News/2016/We-are-delighted-to-announce-that-Anthony-Rosenberg-has-joined-SERODUS-ASA-as-an-advisor